Propiedad y actividad de insiders de Olema Pharmaceuticals, Inc. (OLMA): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $9.73 |
| Capitalización | $850M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $3.1M | $68000 | $338.5M | $13.8M | $23.7M | $68.5M | $139.5M | $48.3M |
| Inversiones a Corto | 0 | 0 | 0 | $273.4M | $180.7M | $193.3M | $294.6M | $457.1M |
| Cuentas por Cobrar | 0 | 0 | 0 | $130000 | $319000 | $673000 | $2.1M | $4.1M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $3.2M | $103000 | $342.1M | $290.7M | $208.9M | $266.5M | $438.5M | $515.5M |
| Inmovilizado Material | $26000 | $26000 | $75000 | $4.7M | $4.0M | $3.3M | $2.1M | $1.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | $683000 | 0 |
| Activos Totales | $3.3M | $132000 | $342.7M | $295.9M | $215.6M | $276.9M | $451.0M | $533.4M |
| Cuentas por Pagar | $116000 | $935000 | $719000 | $23000 | $374000 | $2.7M | $4.5M | $9.3M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $1.2M | $1.1M |
| Pasivos Corrientes | $201000 | $1.4M | $4.6M | $9.0M | $16.5M | $21.6M | $41.8M | $51.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $69000 |
| Pasivos Totales | $9.5M | $10.7M | $4.6M | $11.4M | $18.1M | $23.1M | $42.0M | $54.9M |
| Reservas | -$6.4M | -$10.8M | -$33.1M | -$104.2M | -$209.0M | -$305.6M | -$435.1M | -$597.6M |
| Patrimonio Neto | -$6.3M | -$10.6M | $338.1M | $284.6M | $197.5M | $253.9M | $409.0M | $478.6M |
| Deuda Total | 0 | 0 | 0 | $3.3M | $2.6M | $2.4M | $1.4M | $1.2M |
| Deuda Neta | -$3.1M | -$68000 | -$338.5M | -$284.0M | -$201.9M | -$259.4M | -$432.7M | -$504.2M |
| Capital Circulante | $3.0M | -$1.3M | $337.6M | $281.7M | $192.3M | $244.9M | $396.7M | $463.6M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 8.86 |
Rentabilidad
| Rentabilidad sobre capital | -48.22% |
| Rentabilidad sobre capital invertido | -50.92% |
| Rentabilidad sobre activos | -42.04% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ABSI · CRVS · FDMT · GOSS · KALV · LXRX · PRTA
Explorar sector: Healthcare · Biotechnology
Más secciones de OLMA: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones